Navigation Links
Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public
Date:12/14/2009

SAN FRANCISCO, Dec. 14 /PRNewswire-USNewswire/ -- Environmental health advocates hope that U.S. FDA will make its promised announcement about health hazards of bisphenol A (BPA), a synthetic sex hormone linked to cancer, behavioral changes, reproductive harm and other illnesses, in time for Christmas.

Sarah Janssen, MD, PhD, staff scientist, Natural Resources Defense Council: "Just as you rely on your doctor for medical advice, FDA must rely on the advice of scientific experts. Dozens of independent scientists, including the Director of NIEHS, have recommended avoiding BPA exposure. FDA should heed their guidance and ban BPA in food packaging."

Janet Nudelman, Breast Cancer Fund: "Scientific evidence shows there's no safe level of BPA exposure. The FDA should immediately ban BPA in polycarbonate food containers and require labeling of cans containing BPA."

Urvashi Rangan, PhD, toxicologist with Consumers Union, whose recent study revealing BPA in canned foods was cited by Senators Schumer and Gillibrand: "Consumers can't know how much BPA is in any can of food. The current safety limit for BPA is outdated, using traditional toxicology that doesn't apply to BPA and other endocrine disruptors. BPA has demonstrated adverse effects at very low doses."

"Restrictions on BPA are in place in Connecticut, Minnesota, Chicago, three New York counties, and legislation has been introduced in 21 states," according to Sarah Uhl from Coalition for a Safe and Healthy Connecticut.

Bobbi Chase Wilding of Clean New York is pregnant: "Women of child bearing age and babies are put in danger because this toxic chemical is in products we use. Recent studies find BPA in the bodies of pregnant women and health care providers. FDA must protect us and not delay."

Mike Schade, Center for Health, Environment & Justice. says, "Some local and state governments have banned sales of BPA-contaminated products, and retailers are taking them off their shelves. The FDA needs to act now."

"As we celebrate the Christmas season, we are reminded of Jesus' commitment to those in poverty. We hope that the FDA will take measures to ensure that canned food is BPA-free through the use of safe alternatives in the future," says Chloe Schwabe from the National Council of Churches.

Experts with direct contact info and more details on this story here: http://www.louisvillecharter.org/press.shtml

SOURCE Environmental Health Fund


'/>"/>
SOURCE Environmental Health Fund
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines
2. Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing
3. Pharmateks Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
4. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
5. GEN Reports on the Trend Toward Predictive Toxicogenomics
6. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
7. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
8. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
9. New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
10. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ANGELES (PRWEB) , ... October 12, 2017 , ... ... Parsa Mohebi Hair Restoration, has recently contributed a medical article to the newly ... on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
Breaking Medicine News(10 mins):